Variation in Treatment Preferences and Care Goals Among Older Patients with Diabetes and Their Physicians

Overview

Journal Med Care

Specialty Health Services

Date 2008 Apr 5

PMID 18388842

Citations 23

Authors

Marshall H Chin

Melinda L Drum

Lei Jin

Morgan E Shook

Elbert S Huang

David O Meltzer

Affiliations

Soon will be listed here.

Abstract

Background: Older persons with diabetes are heterogeneous with respect to life expectancy and frailty, and new guidelines recommend individualizing care.

Objectives: (1) To describe variation in the preferences of older patients with diabetes regarding aggressiveness of glycemic control and avoiding diabetic complications. (2) To determine correlates of patient preferences and physician treatment goals. (3) To assess whether physicians' goals were consistent with their patients' preferences.

Research Design: Cross-sectional surveys and chart reviews in urban academic clinics.

Subjects: : Four hundred seventy-three patients with diabetes age 65 or older and 64 physicians.

Measures: Patient preferences (utilities on a scale from 0 to 1, 0 = death, 1 = perfect health) for diabetic complications and intensity of treatment, and physician target treatment goals and ratings of aggressiveness of approach.

Results: Eighty percent of the patients were African American, 63% were women, average age was 73.7 +/- 5.9 years and 26% expected to live 5 years or less. Patient preferences/utilities showed significant variation: blindness 0.39 (SD, 0.32), lower leg amputation 0.45 (0.34), conventional treatment 0.76 (0.27), and intensive insulin treatment 0.64 (0.32). Physicians' hemoglobin A1c goal was < or =7% in 69% of patients. Greater estimated patient life expectancy was consistently associated with higher patient utilities and was associated with physicians' willingness to use aggressive treatments. Physicians' treatment goals and approaches were associated with patients' utilities for treatment.

Conclusions: Older patients vary greatly in their preferences regarding diabetic complications and treatments. Acknowledging patient preferences, along with life goals and prognostic data, may improve quality of treatment decisions.

Citing Articles

The individualisation of glycaemic targets in response to patient characteristics in type 2 diabetes: a scoping review.

Westall S, Narayanan R, Watmough S, Irving G, Furlong N, McNulty S Clin Med (Lond). 2022; 22(3):257-265.

PMID: 35443970 PMC: 9135095. DOI: 10.7861/clinmed.2021-0764.

Methods to Assess Patient Preferences in Old Age Pharmacotherapy - A Systematic Review.

Eidam A, Roth A, Lacroix A, Goisser S, Seidling H, Haefeli W Patient Prefer Adherence. 2020; 14:467-497.

PMID: 32184575 PMC: 7061412. DOI: 10.2147/PPA.S236964.

Changing Results-Engage and Activate to Enhance Wellness: A Randomized Clinical Trial to Improve Cardiovascular Risk Management.

Iturralde E, Sterling S, Uratsu C, Mishra P, Ross T, Grant R J Am Heart Assoc. 2019; 8(23):e014021.

PMID: 31787053 PMC: 6912976. DOI: 10.1161/JAHA.119.014021.

Life Expectancy Predictions for Older Diabetic Patients as Estimated by Physicians and a Prognostic Model.

OHanlon C, Cooper J, Lee S, John P, Churpek M, Chin M MDM Policy Pract. 2018; 2(1):2381468317713718.

PMID: 30288423 PMC: 6124930. DOI: 10.1177/2381468317713718.

Comorbidity Type and Health Care Costs in Type 2 Diabetes: A Retrospective Claims Database Analysis.

Lin P, Pope E, Zhou F Diabetes Ther. 2018; 9(5):1907-1918.

PMID: 30097994 PMC: 6167298. DOI: 10.1007/s13300-018-0477-2.

References

Heisler M, Vijan S, Anderson R, Ubel P, Bernstein S, Hofer T . When do patients and their physicians agree on diabetes treatment goals and strategies, and what difference does it make?. J Gen Intern Med. 2003; 18(11):893-902. PMC: 1494939. DOI: 10.1046/j.1525-1497.2003.21132.x. View

Solomon D, Wenger N, Saliba D, Young R, Adelman A, Besdine R . Appropriateness of quality indicators for older patients with advanced dementia and poor prognosis. J Am Geriatr Soc. 2003; 51(7):902-7. DOI: 10.1046/j.1365-2389.2003.513331.x. View

OConnor A, Stacey D, Entwistle V, Llewellyn-Thomas H, ROVNER D, Holmes-Rovner M . Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2003; (2):CD001431. DOI: 10.1002/14651858.CD001431. View

Mokdad A, Ford E, Bowman B, Nelson D, Engelgau M, Vinicor F . Diabetes trends in the U.S.: 1990-1998. Diabetes Care. 2000; 23(9):1278-83. DOI: 10.2337/diacare.23.9.1278. View

Brown M, Brown G, Sharma S, Shah G . Utility values and diabetic retinopathy. Am J Ophthalmol. 1999; 128(3):324-30. DOI: 10.1016/s0002-9394(99)00146-4. View

Mossey J, Shapiro E . Self-rated health: a predictor of mortality among the elderly. Am J Public Health. 1982; 72(8):800-8. PMC: 1650365. DOI: 10.2105/ajph.72.8.800. View

Huang E, Shook M, Jin L, Chin M, Meltzer D . The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes. Diabetes Care. 2006; 29(2):259-64. PMC: 2292131. DOI: 10.2337/diacare.29.02.06.dc05-1443. View

Harris M, Flegal K, Cowie C, Eberhardt M, Goldstein D, LITTLE R . Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998; 21(4):518-24. DOI: 10.2337/diacare.21.4.518. View

Huang E, Gorawara-Bhat R, Chin M . Self-reported goals of older patients with type 2 diabetes mellitus. J Am Geriatr Soc. 2005; 53(2):306-11. PMC: 2291346. DOI: 10.1111/j.1532-5415.2005.53119.x. View

10.

Brown G, Brown M, Sharma S, Brown H, Gozum M, Denton P . Quality of life associated with diabetes mellitus in an adult population. J Diabetes Complications. 2000; 14(1):18-24. DOI: 10.1016/s1056-8727(00)00061-1. View

11.

Tennvall G, Apelqvist J . Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complications. 2000; 14(5):235-41. DOI: 10.1016/s1056-8727(00)00133-1. View

12.

Katz S, Ford A, Moskowitz R, Jackson B, JAFFE M . STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. JAMA. 1963; 185:914-9. DOI: 10.1001/jama.1963.03060120024016. View

13.

Wexler D, Grant R, Wittenberg E, Bosch J, Cagliero E, Delahanty L . Correlates of health-related quality of life in type 2 diabetes. Diabetologia. 2006; 49(7):1489-97. DOI: 10.1007/s00125-006-0249-9. View

14.

Redelmeier D, Detsky A . A clinician's guide to utility measurement. Prim Care. 1995; 22(2):271-80. View

15.

Welch H, Albertsen P, Nease R, Bubolz T, Wasson J . Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med. 1996; 124(6):577-84. DOI: 10.7326/0003-4819-124-6-199603150-00007. View

16.

. American Diabetes Association: clinical practice recommendations 1997. Diabetes Care. 1997; 20 Suppl 1:S1-70. View

17.

Brown M, Brown G, Sharma S, Busbee B . Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states. Ophthalmology. 2003; 110(6):1076-81. DOI: 10.1016/S0161-6420(03)00254-9. View

18.

Sharma S, Oliver-Fernandez A, Bakal J, Hollands H, Brown G, Brown M . Utilities associated with diabetic retinopathy: results from a Canadian sample. Br J Ophthalmol. 2003; 87(3):259-61. PMC: 1771570. DOI: 10.1136/bjo.87.3.259. View

19.

Coffey J, Brandle M, Zhou H, Marriott D, Burke R, Tabaei B . Valuing health-related quality of life in diabetes. Diabetes Care. 2002; 25(12):2238-43. DOI: 10.2337/diacare.25.12.2238. View

20.

Naglie G, Krahn M, Naimark D, Redelmeier D, Detsky A . Primer on medical decision analysis: Part 3--Estimating probabilities and utilities. Med Decis Making. 1997; 17(2):136-41. DOI: 10.1177/0272989X9701700203. View